Package 0121-0670-16

Brand: ethosuximide

Generic: ethosuximide
NDC Package

Package Facts

Identity

Package NDC 0121-0670-16
Digits Only 0121067016
Product NDC 0121-0670
Product ID 0121-0670_14d8b71e-abd8-49d4-b4cc-82880e54db8c
Description

473 mL in 1 BOTTLE (0121-0670-16)

Marketing

Marketing Status
Marketed Since 2000-11-22
Brand ethosuximide
Generic ethosuximide
Sample Package No

Linked Drug Pages (1)

ETHOSUXIMIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "14d8b71e-abd8-49d4-b4cc-82880e54db8c", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0301210670169"], "unii": ["5SEH9X1D1D"], "rxcui": ["251322"], "spl_set_id": ["8a5cc930-0b36-48a8-9ad0-de633b208742"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["PAI Holdings, LLC dba PAI Pharma"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (0121-0670-16)", "package_ndc": "0121-0670-16", "marketing_start_date": "20001122"}], "brand_name": "ETHOSUXIMIDE", "product_id": "0121-0670_14d8b71e-abd8-49d4-b4cc-82880e54db8c", "dosage_form": "SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0121-0670", "generic_name": "ETHOSUXIMIDE", "labeler_name": "PAI Holdings, LLC dba PAI Pharma", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ETHOSUXIMIDE", "active_ingredients": [{"name": "ETHOSUXIMIDE", "strength": "250 mg/5mL"}], "application_number": "ANDA040253", "marketing_category": "ANDA", "marketing_start_date": "20001122", "listing_expiration_date": "20261231"}